U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H17N3.ClH
Molecular Weight 287.787
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BESIPIRDINE HYDROCHLORIDE

SMILES

Cl.CCCN(N1C=CC2=C1C=CC=C2)C3=CC=NC=C3

InChI

InChIKey=ZDFVWDHZXAGROF-UHFFFAOYSA-N
InChI=1S/C16H17N3.ClH/c1-2-12-18(15-7-10-17-11-8-15)19-13-9-14-5-3-4-6-16(14)19;/h3-11,13H,2,12H2,1H3;1H

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C16H17N3
Molecular Weight 251.3263
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: http://www.evaluategroup.com/Universal/View.aspx?type=Story&id=269038 | http://adisinsight.springer.com/drugs/800001339 | https://www.ncbi.nlm.nih.gov/pubmed/9103515 | https://www.ncbi.nlm.nih.gov/pubmed/7674813

Besipirdine is a potential novel first-in-class oral treatment for over active bladder currently in Phase II development, with a mechanism of action clearly different from that of antimuscarinics. It was under evaluation by Aventis up to phase III for Alzheimer’s disease, involving the administration of the compound to over 1500 patients. However, this research has been discontinued. Besipirdine antagonizes alpha-2 and alpha-1 adrenoceptors and inhibits both norepinephrine and serotonin uptake. The most common adverse events were asymptomatic postural hypotension and asymptomatic bradycardia.

Approval Year

PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

5 and 20 mg b.i.d.
Route of Administration: Oral
In Vitro Use Guide
Besipirdine inhibited [3H]-batrachotoxin binding (IC50 = 5.5 uM) in a rat brain vesicular preparation and concentration-dependently inhibited veratridine (25 uM)-stimulated increases in intracellular free sodium ([Na+]i) and calcium ([Ca2+]i) in primary cultured cortical neurones of rat. Besipirdine (30-100 uM) concentration-dependently inhibited (up to 100%) veratridine-stimulated release of [3H]-noradrenaline (NA) from rat cortical slices.
Substance Class Chemical
Created
by admin
on Sat Dec 16 05:01:07 GMT 2023
Edited
by admin
on Sat Dec 16 05:01:07 GMT 2023
Record UNII
2541WG0P2F
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BESIPIRDINE HYDROCHLORIDE
MI   USAN   WHO-DD  
USAN  
Official Name English
1H-INDOL-1-AMINE, N-PROPYL-N-4-PYRIDINYL-, MONOHYDROCHLORIDE
Common Name English
1-(Propyl-4-pyridylamino)indole monohydrochloride
Systematic Name English
Besipirdine hydrochloride [WHO-DD]
Common Name English
HP-749
Code English
BESIPIRDINE HCL
Common Name English
HP 749
Code English
BESIPIRDINE HYDROCHLORIDE [USAN]
Common Name English
BESIPIRDINE HYDROCHLORIDE [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C87053
Created by admin on Sat Dec 16 05:01:07 GMT 2023 , Edited by admin on Sat Dec 16 05:01:07 GMT 2023
Code System Code Type Description
EVMPD
SUB00766MIG
Created by admin on Sat Dec 16 05:01:07 GMT 2023 , Edited by admin on Sat Dec 16 05:01:07 GMT 2023
PRIMARY
USAN
DD-43
Created by admin on Sat Dec 16 05:01:07 GMT 2023 , Edited by admin on Sat Dec 16 05:01:07 GMT 2023
PRIMARY
ChEMBL
CHEMBL29835
Created by admin on Sat Dec 16 05:01:07 GMT 2023 , Edited by admin on Sat Dec 16 05:01:07 GMT 2023
PRIMARY
SMS_ID
100000085003
Created by admin on Sat Dec 16 05:01:07 GMT 2023 , Edited by admin on Sat Dec 16 05:01:07 GMT 2023
PRIMARY
EPA CompTox
DTXSID20156811
Created by admin on Sat Dec 16 05:01:07 GMT 2023 , Edited by admin on Sat Dec 16 05:01:07 GMT 2023
PRIMARY
MERCK INDEX
m1024
Created by admin on Sat Dec 16 05:01:07 GMT 2023 , Edited by admin on Sat Dec 16 05:01:07 GMT 2023
PRIMARY Merck Index
NCI_THESAURUS
C90630
Created by admin on Sat Dec 16 05:01:07 GMT 2023 , Edited by admin on Sat Dec 16 05:01:07 GMT 2023
PRIMARY
PUBCHEM
68742
Created by admin on Sat Dec 16 05:01:07 GMT 2023 , Edited by admin on Sat Dec 16 05:01:07 GMT 2023
PRIMARY
FDA UNII
2541WG0P2F
Created by admin on Sat Dec 16 05:01:07 GMT 2023 , Edited by admin on Sat Dec 16 05:01:07 GMT 2023
PRIMARY
CAS
130953-69-4
Created by admin on Sat Dec 16 05:01:07 GMT 2023 , Edited by admin on Sat Dec 16 05:01:07 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY